Scorpius Holdings, Inc. (SCPX)
| Market Cap | 128.40K -19.2% |
| Revenue (ttm) | 1.72M -82.9% |
| Net Income | -25.18M |
| EPS | -0.85 |
| Shares Out | 61.14M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 60,814 |
| Open | 0.0021 |
| Previous Close | 0.0011 |
| Day's Range | 0.0021 - 0.0021 |
| 52-Week Range | 0.0001 - 0.1000 |
| Beta | -4.97 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 17, 2026 |
About Scorpius Holdings
Scorpius Holdings, Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company engages in clinical and commercial drug substance manufacturing; and release and stability testing activities. It is also involved in the provision of various process development services, including upstream and downstream development and optimization, and analytical method development solutions, as well as cell line development, testing, and characterization services. The company ... [Read more]
Financial Performance
In 2024, Scorpius Holdings's revenue was $6.24 million, a decrease of -10.75% compared to the previous year's $6.99 million. Losses were -$32.81 million, -27.44% less than in 2023.
Financial StatementsNews
Biotech Alert: Searches spiking for these stocks today
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Scorpius Holdings (SCPX), 1,095.65% surge in interest Pip...
Tivic Health acquires manufacturing, development assets of Scorpius Holdings
Tivic Health Systems (TIVC) has acquired the strategic manufacturing and development assets of Scorpius Holdings (SCPX) and is launching Velocity Bioworks, a wholly owned subsidiary of Tivic, to provi...
Scorpius Holdings announces cost optimization including 28% headcount reduction
Scorpius Holdings (SCPX) provided a corporate update highlighting key strategic initiatives, including cost optimization measures expected to yield over $6 million in annualized savings and the Compan...
Scorpius Holdings Announces Corporate Update Including Cost Optimization Initiatives, Strategic Corporate Developments, and Potential Opportunities for Expansion into Southeast Asia
Operational Realignment Expected to Deliver Over $6 Million in Annual Cost Savings Company Exploring CDMO Expansion Opportunities in Southeast Asia San Antonio, TX, May 04, 2025 (GLOBE NEWSWIRE) -- Sc...
Scorpius Holdings Provides 2024 Year-End Business Update; Implements Strategic Cost Reductions and Operational Streamlining
SAN ANTONIO, April 30, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (OTC: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization ("CDMO”), today prov...
Scorpius Holdings Receives NYSE American Notice of Delisting and Reports Plans to Appeal
San Antonio, TX, April 21, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization (“CDMO...
NYSE American to commence delisting proceedings against Scorpius Holdings
NYSE American announced that the staff of NYSE Regulation has determined to commence proceedings to delist the common stock of Scorpius Holdings (SCPX) – ticker symbol SCPX- from NYSE American.
NYSE American to Commence Delisting Proceedings Against Scorpius Holdings, Inc. (SCPX)
NEW YORK--(BUSINESS WIRE)--NYSE American LLC (“NYSE American” or the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the common stock of ...
Scorpius engages Alliance Global Partners to explore strategic alternatives
Scorpius Holdings (SCPX) has engaged Alliance Global Partners to assist in exploring strategic alternatives for the Company. This engagement is part of the Company’s ongoing efforts to maximize shareh...
Scorpius Holdings Engages Alliance Global Partners to Explore Strategic Alternatives
DURHAM, N.C., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization ("CDMO"), ...
Scorpius Holdings announces collaboration with KaloCyte
Scorpius announced its collaboration with KaloCyte. Under this initial project, Scorpius will utilize its scientific and technical expertise to enhance manufacturing efficiencies for KaloCyte’s lead c...
Scorpius Holdings Announces Collaboration with KaloCyte to Advance Manufacturing for ErythroMer™
Partnership highlights Scorpius' expertise in supporting innovative therapeutic programs Partnership highlights Scorpius' expertise in supporting innovative therapeutic programs
Scorpius Holdings cancels planned 1-for-20 reverse stock split
Scorpius Holdings (SCPX) announced that the company’s planned 1-for-20 reverse stock split of its common stock that was announced yesterday, will not be effectuated.
Scorpius Holdings Cancels Planned Reverse Stock Split
DURHAM, N.C., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization (“CDMO”), ...
Scorpius Holdings announces 1-for-20 reverse stock split
Scorpius Holdings announced that the company’s board of directors approved a 1-for-20 reverse stock split of the company’s common stock, to increase the selling price of the company’s common stock…
Scorpius Holdings Announces Reverse Stock Split
DURHAM, N.C., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization (“CDMO”), ...
Scorpius Holdings files to sell 29.41M shares of common stock, warrants
ThinkEquity is acting as manager.
Scorpius Holdings files to sell 47.4M shares of common stock for holders
06:11 EST Scorpius Holdings (SCPX) files to sell 47.4M shares of common stock for holders
Scorpius Holdings launches Scorpius Ventures
Scorpius announced the launch of Scorpius Ventures, a new business unit designed to support emerging biotech companies with a flexible American onshoring model. By combining service fees with an equit...
Scorpius Holdings Launches Scorpius Ventures to Support U.S. Biotech Innovation through Flexible Equity-Based Onshoring Model
New business unit offers services for promising biotech companies through combined fee-for-service and equity-based model, fostering partnerships that align with BIOSECURE Act goals to onshore and str...
Scorpius Holdings Reports Third Quarter 2024 Results, Highlighting Strategic Partnerships, Cost Savings, and Progress Toward Profitability
DURHAM, N.C., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization (“CDMO”), ...
Scorpius Holdings announces collaboration with Celltheon Corp
Scorpius announced a partnership with Celltheon Corporation to provide cell line development services to clients using Celltheon’s proprietary GOLDILOCKS transposase-based platform. This collaboration...
Scorpius Holdings Announces Collaboration with Celltheon Corporation, a U.S.-Based Cell Line Development Company; First Client Signed Under New Partnership Agreement
DURHAM, N.C., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization ("CDMO"), ...
Scorpius Holdings announces implementation of new cost saving measures
Scorpius Holdings (SCPX) announced the implementation of strategic cost-saving measures expected to save over $2M annually. The recently implemented measures include the divestiture of certain non-cor...
Scorpius Holdings Announces Implementation of New Cost Savings Measures Expected to Save Over $2 Million Annually
DURHAM, N.C., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or the “Company”), an integrated biomanufacturing company, today announced the implementation o...